Market Overview

Morgan Stanley: Taubman Could Be More Attractive M&A Candidate Than Macerich

Share:
Morgan Stanley: Taubman Could Be More Attractive M&A Candidate Than Macerich

Among mall REITs, Taubman Centers, Inc. (NYSE: TCO) and Macerich Co (NYSE: MAC) have underperformed relative to  Simon Property Group Inc (NYSE: SPG), primarily due to the greater cash flow headwinds the former two face, according to Morgan Stanley.

The Analyst

Analyst Richard Hill upgraded Taubman from Underweight to Equal-weight and trimmed the price target from $51.50 to $50.

The analyst downgraded Macerich from Equal-weight to Underweight and reduced the price target from $58 to $45.

The Thesis

Even as cash flow headwinds persist, Taubman is likely to see its free cash flow inflect higher over the next two years, while Macerich's is expected to continue to decline, Hill said in a Monday note. (See his track record here.) 

The analyst said he's skeptical of the consensus belief that Macerich is a more likely M&A candidate than Taubman due to the following reasons:

Taubman's board now has an activist investor, and six board seats are coming up for re-election next summer; activists have exited positions in Macerich.

Taubman has higher quality assets and a debt-to-cap of 47 percent, which suggests the company has an increased likelihood of taking itself private.

The economics of third-party M&A are not obvious at the current share price, assuming a 10-percent required internal rate of return.

Hill sees higher upside potential for Taubman based on consensus NAV.

Morgan Stanley reduced its 2019 and 2020 FFO estimates for Taubman by 14 cents each to $3.61 and $3.76, respectively. That said, the analyst sees the FFO inflecting higher from an estimated $6.7 million in 2018 to $112 million in 2019 and $252 million in 2020.

The sell-side firm reduced its 2019 and 2020 FFO estimates for Macerich by 6 cents and 5 cents, respectively, to $3.96 and $4.07. The FFO is set to decline from an estimated $598 million in 2018 to $312 million in 2019 before rising to $334 million in 2020, Hill said. 

The Price Action

For the year-to-date period, Taubman shares have lost 19.7 percent and Macerich has slumped 21.5 percent.

Taubman was up 2.38 percent at $52 at the close Tuesday, while Macerich was down 0.49 percent at $48.70. 

Related Links:

REIT Pair Trade: Morgan Stanley Upgrades Store Capital, Downgrades Realty Income

What's At Stake For Shopping Mall REIT Taubman As Activist Clash Comes To A Climax

Latest Ratings for MAC

DateFirmActionFromTo
Oct 2019ReiteratesNeutral
Sep 2019MaintainsNeutral
Sep 2019DowngradesOutperformMarket Perform

View More Analyst Ratings for MAC
View the Latest Analyst Ratings

Posted-In: Morgan Stanley retail Richard HillAnalyst Color Upgrades Downgrades Price Target Analyst Ratings Best of Benzinga

 

Related Articles (MAC + SPG)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
PTONBank of AmericaInitiates Coverage On29.0
ITRICanaccord GenuityMaintains87.0
GWPHNeedhamInitiates Coverage On200.0
BABairdDowngrades
LUVStifelDowngrades60.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

GW Pharma Beats Q4 EPS Estimates, Misses On Revenue

South Korea Legalizes Medical Marijuana